Pfizer to ask FDA to authorize boosters for people 16-17, source says

Pfizer is going to ask the Food and Drug Administration in the coming days to authorize COVID-19 booster shots for 16- and 17-year-olds, a source familiar with the discussions confirmed to ABC News.

This would expand booster access from everyone over 18 to everyone over 16.

Pfizer vaccines were authorized for adolescents in May, so many fully vaccinated people are nearing their six-month mark amid growing concern over the omicron variant.

As the COVID-19 pandemic has swept the globe, more than 5.2 million people have died from the disease worldwide, including over 777,000 Americans, according to real-time data compiled by Johns Hopkins University’s Center for Systems Science and Engineering.

Just 59.1% of the population in the United States is fully vaccinated against COVID-19, according to data from the Centers for Disease Control and Prevention.